Liminatus Pharma, Inc. Class A Common Stock(LIMN)

Biotechnology · Cerritos, CA

$3.70-0.29 (-7.27%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T20:42:05.883Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:42:05.883Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 4,969,866
TTM free cash flow · period ending 2026-06-30: -3,985,858

FMP input reference: d2baa5019f568993ecceb1943c30cf17443c8d153a00c2cc4d930c3e59df60e4

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LIMN Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

LIMN Competitors' Price/FCF Ratio

LIMN

Liminatus Pharma, Inc. Class A Common Stock

Current

Market Cap

$4.97M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

XBIO

Xenetic Biosciences, Inc.

vs LIMN

Market Cap

$4.86M

Price/FCF Ratio

N/A

TTM Avg

11.23

3Y Avg

11.23

5Y Avg

11.23

LNAI

Lunai Bioworks Inc.

vs LIMN

Market Cap

$5.12M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALZN

Alzamend Neuro Inc

vs LIMN

Market Cap

$5.21M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMGL

Basel Medical Group Ltd Ordinary Shares

vs LIMN

Market Cap

$5.21M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs LIMN

Market Cap

$4.72M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PULM

Pulmatrix, Inc.

vs LIMN

Market Cap

$5.22M

Price/FCF Ratio

N/A

TTM Avg

6.36

3Y Avg

6.36

5Y Avg

6.36

IMNN

Imunon, Inc.

vs LIMN

Market Cap

$4.71M

Price/FCF Ratio

N/A

TTM Avg

15.88

3Y Avg

17.94

5Y Avg

17.94

INBS

Intelligent Bio Solutions Inc.

vs LIMN

Market Cap

$5.24M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CALC

CalciMedica, Inc.

vs LIMN

Market Cap

$4.69M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Liminatus Pharma, Inc. Class A Common Stock (LIMN)	$4.97M	N/A	N/A	N/A	N/A
Xenetic Biosciences, Inc. (XBIO)vs ›	$4.86M	N/A	11.23	11.23	11.23
Lunai Bioworks Inc. (LNAI)vs ›	$5.12M	N/A	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.21M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.21M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.72M	N/A	N/A	N/A	N/A
Pulmatrix, Inc. (PULM)vs ›	$5.22M	N/A	6.36	6.36	6.36
Imunon, Inc. (IMNN)vs ›	$4.71M	N/A	15.88	17.94	17.94
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.24M	N/A	N/A	N/A	N/A
CalciMedica, Inc. (CALC)vs ›	$4.69M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

LIMN Price/FCF Ratio Metrics

LIMN Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics